What is the prognosis of neutrophilic eccrine hidradenitis (NEH)?

Updated: Jun 22, 2021
  • Author: Joseph C Pierson, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Many patients experience recurrent symptoms with subsequent courses of chemotherapy. One patient avoided painful recurrences with prophylactic dapsone. Possible hematologic toxicity with dapsone in the setting of chemotherapy regimens is a concern. [29] Neutrophilic eccrine hidradenitis (NEH) is typically a self-limited process. It does not appear to portend a worse prognosis for the underlying malignancy when occurring in that setting.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!